Equities

AMN Healthcare Services Inc

AMN Healthcare Services Inc

Actions
IndustrialsIndustrial Support Services
  • Price (USD)26.23
  • Today's Change0.530 / 2.06%
  • Shares traded199.42k
  • 1 Year change-61.32%
  • Beta0.0676
Data delayed at least 15 minutes, as of Nov 22 2024 17:50 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
  • 21-Nov-24
Select bar for recommendation details.
Recommendations21-Nov-24
Buy0
Outperform3
Hold5
Sell1
Strong Sell0

Share price forecast in USD

The 7 analysts offering 12 month price targets for AMN Healthcare Services, Inc. have a median target of 43.00, with a high estimate of 47.00 and a low estimate of 27.00. The median estimate represents a 67.32% increase from the last price of 25.70.
High82.9%47.00
Med67.3%43.00
Low5.1%27.00

Earnings history & estimates in USD

On Nov 07, 2024, AMN Healthcare Services, Inc. reported 3rd quarter 2024 earnings of 0.61 per share. This result exceeded the 0.57 consensus of the 9 analysts covering the company and under-performed last year's 3rd quarter results by 69.04%.
The next earnings announcement is expected on Feb 13, 2025.
Average growth rate-4.72%
AMN Healthcare Services, Inc. reported annual 2023 earnings of 8.21 per share on Feb 15, 2024.
Average growth rate+39.79%
More ▼

Revenue history & estimates in USD

AMN Healthcare Services, Inc. had 3rd quarter 2024 revenues of 687.51m. This bettered the 671.45m consensus of the 8 analysts covering the company. This was 38.95% below the prior year's 3rd quarter results.
Average growth rate-5.19%
AMN Healthcare Services, Inc. had revenues for the full year 2023 of 3.79bn. This was 27.73% below the prior year's results.
Average growth rate+19.51%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.